HRCM
ANIP icon

Hawk Ridge Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Hawk Ridge Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-196,661
Closed -$8.01M – 43
2020
Q1 		$8.01M Buy
196,661
+7,900
+4% +$420K 1.35% 24
2019
Q4 		$11.6M Buy
188,761
+33,800
+22% +$2.24M 1.89% 23
2019
Q3 		$11.3M Buy
154,961
+31,400
+25% +$2.35M 2.26% 16
2019
Q2 		$10.2M Hold
123,561
– – 1.88% 23
2019
Q1 		$8.72M Buy
+123,561
New +$7.27M 1.84% 25

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return